Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation

Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation

The risk stratification of patients with atrial fibrillation (AF) for subsequent cardiovascular events could help in guiding prevention strategies. In this study, we aimed at investigating circulating microRNAs as prognostic biomarkers for major adverse cardiovascular events (MACE) in AF patients. W...

Full description

Bibliographic Details
Main Authors:	Stephan Nopp, M. Leontien van der Bent, Daniel Kraemmer, Oliver Königsbrügge, Johann Wojta, Ingrid Pabinger, Cihan Ay, Anne Yaël Nossent
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	circulating microRNA atrial fibrillation biomarkers sequence analysis RNA humans
Online Access:	https://www.mdpi.com/1422-0067/24/4/3861

Similar Items

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
by: Oliver Königsbrügge, et al.
Published: (2019-10-01)

Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study
by: Daniel Steiner, et al.
Published: (2022-11-01)

Atrial Fibrillation and MicroRNAs
by: Gaetano eSantulli, et al.
Published: (2014-01-01)

The Integrative Regulatory Network of circRNA, microRNA, and mRNA in Atrial Fibrillation
by: Shengyang Jiang, et al.
Published: (2019-06-01)

Progress of circRNA/lncRNA-miRNA-mRNA axis in atrial fibrillation
by: Jia-le Wen, et al.
Published: (2023-12-01)

Exploratory Analysis of Circulating miRNA Signatures in Atrial Fibrillation Patients Determining Potential Biomarkers to Support Decision-Making in Anticoagulation and Catheter Ablation
by: Naoki Kiyosawa, et al.
Published: (2020-04-01)

Diagnostic accuracy of MicroRNA 208b level with respect to different types of atrial fibrillation
by: Abraham Paul, MD, DM, et al.
Published: (2021-07-01)

Extracellular Vesicles in Atrial Fibrillation—State of the Art
by: Grzegorz Procyk, et al.
Published: (2022-07-01)

Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation
by: Huaiguang Tang, et al.
Published: (2024-04-01)

Analysis of infiltrated immune cells in left atriums from patients with atrial fibrillation and identification of circRNA biomarkers for postoperative atrial fibrillation
by: Yubin Chen, et al.
Published: (2022-12-01)

Identification of microRNAs as diagnostic biomarkers for atrial fibrillation: a systematic review and meta-analysis
by: Ardian Rizal, et al.
Published: (2023-04-01)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
by: Stephan Nopp, et al.
Published: (2022-05-01)

Elevated Plasma Levels of Circulating Extracellular miR-320a-3p in Patients with Paroxysmal Atrial Fibrillation
by: Andrey V. Zhelankin, et al.
Published: (2020-05-01)

Dissecting the Molecular Mechanisms Driving Electropathology in Atrial Fibrillation: Deployment of RNA Sequencing and Transcriptomic Analyses
by: Fabries G. Huiskes, et al.
Published: (2023-09-01)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01)

Identification of functional lncRNAs in atrial fibrillation based on RNA sequencing
by: Yangyang You, et al.
Published: (2023-11-01)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
by: Xiyu Zhu, et al.
Published: (2020-11-01)

MicroRNA as a novel player in atrial fibrillation
by: Siyi eFu, et al.
Published: (2014-04-01)

Integrated Analysis of circRNA-miRNA-mRNA-Mediated Network and Its Potential Function in Atrial Fibrillation
by: Feiyu Wei, et al.
Published: (2022-06-01)

Insights from computational modeling on the potential hemodynamic effects of sinus rhythm versus atrial fibrillation
by: Matteo Anselmino, et al.
Published: (2022-09-01)

Integrated Analysis of the microRNA–mRNA Network Predicts Potential Regulators of Atrial Fibrillation in Humans
by: Rong Wang, et al.
Published: (2022-08-01)

The Role of Exosomes and Their Cargos in the Mechanism, Diagnosis, and Treatment of Atrial Fibrillation
by: Shengyuan Huang, et al.
Published: (2021-07-01)

Pulmonary embolism during the COVID‐19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
by: Stephan Nopp, et al.
Published: (2020-07-01)

Epidemiology, risk profile, management, and outcome in geriatric patients with atrial fibrillation in two long-term care hospitals
by: Gernot Wagner, et al.
Published: (2022-11-01)

Molecular Mechanisms, Diagnostic Aspects and Therapeutic Opportunities of Micro Ribonucleic Acids in Atrial Fibrillation
by: Allan Böhm, et al.
Published: (2020-04-01)

C/D box snoRNA SNORD113-6 guides 2′-O-methylation and protects against site-specific fragmentation of tRNALeu(TAA) in vascular remodeling
by: Eva van Ingen, et al.
Published: (2022-12-01)

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
by: Cornelia Englisch, et al.
Published: (2022-12-01)

Recent advances in the genetics of atrial fibrillation: from rare and common genetic variants to microRNA signaling
by: Heidi Estner, et al.
Published: (2011-12-01)

Circulatory MicroRNAs in Plasma and Atrial Fibrillation in the General Population: The Rotterdam Study
by: Sven Geurts, et al.
Published: (2021-12-01)

Integrative Analysis Reveals Key Circular RNA in Atrial Fibrillation
by: Xiaofeng Hu, et al.
Published: (2019-02-01)

Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis
by: Antônio da Silva Menezes Junior, et al.
Published: (2023-02-01)

Editorial: MicroRNAs—clinical biomarkers for atrial fibrillation
by: Isabel Moscoso, et al.
Published: (2023-09-01)

Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
by: Panjaree Siwaponanan, et al.
Published: (2022-01-01)

Circular RNAs in atrial fibrillation: From bioinformatics analysis of circRNA-miRNA-mRNA network to serum expression
by: Zongqian Xue, et al.
Published: (2023-12-01)

RNAs and Gene Expression Predicting Postoperative Atrial Fibrillation in Cardiac Surgery Patients Undergoing Coronary Artery Bypass Grafting
by: Muhammad Shuja Khan, et al.
Published: (2020-04-01)

MicroRNAs Regulate TASK‐1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation
by: Felix Wiedmann, et al.
Published: (2022-04-01)

The Chinese burden of atrial fibrillation review of atrial fibrillation studies in China
by: Jianshu Song
Published: (2022-11-01)

Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation
by: Mateusz Polak, et al.
Published: (2024-03-01)

Identifying ceRNA Networks Associated With the Susceptibility and Persistence of Atrial Fibrillation Through Weighted Gene Co-Expression Network Analysis
by: Yaozhong Liu, et al.
Published: (2021-06-01)

The roles of long noncoding RNAs in atrial fibrillation
by: Ozal Beylerli, et al.
Published: (2023-12-01)